Theriva Biologics (NYSE American: TOVX) announced it will present clinical outcomes and safety data from a Phase 1 study of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE